The 2021 conference of the American Diabetes Association (ADA) has concluded. This year, the focus was on the pandemic and the many ways it affected people with diabetes.
In our latest HealthDay Now, Mabel Jong spoke with Dr. Robert Gabbay, the ADA's chief scientific and medical officer. Dr. Gabbay shared important takeaways from the meeting and addressed insulin prices and racial disparities in diabetes care.
Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.